Susquehanna International Group, LLP Lucira Health, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.94 $55,974 - $153,151	-38,871 Reduced 57.68%	28,521 $53,000
Q1 2022 May 16, 2022	SELL	$2.86 - $8.83 $277,763 - $857,569	-97,120 Reduced 59.04%	67,392 $241,000
Q4 2021 Feb 14, 2022	BUY	$4.94 - $8.94 $279,312 - $505,476	56,541 Added 52.37%	164,512 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.81 $456,448 - $815,571	75,446 Added 231.96%	107,971 $821,000
Q2 2021 Aug 11, 2021	BUY	$4.56 - $11.45 $52,125 - $130,884	11,431 Added 54.19%	32,525 $216,000

Q1 2021 May 17, 2021	BUY	$11.65 - $37.0 $245,745 - $780,478	21,094 New	21,094 $255,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.